Advertisement
Advertisement
U.S. Markets open in 8 hrs 46 mins
Advertisement
Advertisement
Advertisement
Advertisement

Viveve Medical, Inc. (VIVE)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.7900-0.0068 (-0.85%)
At close: 04:00PM EDT
0.7812 -0.01 (-1.11%)
After hours: 07:58PM EDT
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 5/18/2022
Current
Market Cap (intraday)
N/A
Enterprise Value
N/A
Trailing P/E
N/A
Forward P/E
N/A
PEG Ratio (5 yr expected)
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue
N/A
Enterprise Value/EBITDA
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.63
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 33.2200
52 Week Low 30.7400
50-Day Moving Average 30.9397
200-Day Moving Average 31.5647

Share Statistics

Avg Vol (3 month) 368.68k
Avg Vol (10 day) 336.53k
Shares Outstanding 510.6M
Implied Shares Outstanding 6N/A
Float 810.62M
% Held by Insiders 10.00%
% Held by Institutions 110.79%
Shares Short (Apr 28, 2022) 4102.13k
Short Ratio (Apr 28, 2022) 41.7
Short % of Float (Apr 28, 2022) 40.96%
Short % of Shares Outstanding (Apr 28, 2022) 40.96%
Shares Short (prior month Mar 30, 2022) 498.09k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Dec 01, 2020
Ex-Dividend Date 4N/A
Last Split Factor 21:10
Last Split Date 3Dec 01, 2020

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Dec 30, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-335.40%

Management Effectiveness

Return on Assets (ttm)-63.33%
Return on Equity (ttm)-197.56%

Income Statement

Revenue (ttm)6.43M
Revenue Per Share (ttm)0.64
Quarterly Revenue Growth (yoy)-12.40%
Gross Profit (ttm)620k
EBITDA -20.43M
Net Income Avi to Common (ttm)-26.72M
Diluted EPS (ttm)-3.1330
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)19.16M
Total Cash Per Share (mrq)1.8
Total Debt (mrq)5.68M
Total Debt/Equity (mrq)37.67
Current Ratio (mrq)4.91
Book Value Per Share (mrq)1.92

Cash Flow Statement

Operating Cash Flow (ttm)-12.88M
Levered Free Cash Flow (ttm)-6.51M
Advertisement
Advertisement